Opus Point Partners Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-29,934
Closed -$220K 60
2017
Q2
$220K Sell
29,934
-23,223
-44% -$171K 0.2% 54
2017
Q1
$396K Buy
53,157
+14,210
+36% +$106K 0.29% 47
2016
Q4
$271K Buy
38,947
+15,353
+65% +$107K 0.22% 40
2016
Q3
$194K Sell
23,594
-632
-3% -$5.2K 0.11% 44
2016
Q2
$196K Buy
+24,226
New +$196K 0.19% 41